Page last updated: 2024-10-21

zopolrestat and Alzheimer Disease

zopolrestat has been researched along with Alzheimer Disease in 1 studies

zopolrestat: structure given in first source

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, XM1
Yu, Q1
Dong, X1
Yang, HO1
Zeng, KW1
Li, J1
Tu, PF1

Other Studies

1 other study available for zopolrestat and Alzheimer Disease

ArticleYear
Aldose reductase inhibitors attenuate β-amyloid-induced TNF-α production in microlgia via ROS-PKC-mediated NF-κB and MAPK pathways.
    International immunopharmacology, 2017, Volume: 50

    Topics: Aldehyde Reductase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzothiazoles; Cell Line; Cy

2017